dexcom g6 pro cgm (Dexcom Inc)
86
Structured Review
Dexcom Inc
dexcom g6 pro cgm
Dexcom G6 Pro Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexcom+g6+cgm+system/dexcom+g6+pro+%E2%80%A2/pm42251767-53-1-5
Average 86 stars, based on 1 article reviews
Dexcom G6 Pro Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexcom+g6+cgm+system/dexcom+g6+pro+%E2%80%A2/pm42251767-53-1-5
Average 86 stars, based on 1 article reviews
dexcom g6 pro cgm - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Control:Article Title: Real‐World Experience With Control‐IQ Technology in Saudi Children With Insulin‐Dependent Diabetes: A Single‐Center Observational Study Article Snippet: .. Our participants used the Article Title: Improving kidney transplant care through the application of continuous glucose monitoring - a narrative review Article Snippet: Jandovitz et al ( ) , 2023 , USA , Clinical Transplant , Prospective randomized controlled trial , 40 , Kidney transplant Medtronic , To examine whether the use of inpatient Continuous Glucose Monitors provides improved glycemic control over finger-stick glucose monitoring post-transplant. , Patients on CGM has significantly reduced incidence of hyperglycaemic episodes and median glucose levels in the first 5 days post-transplant without increasing the number of hypoglycaemic episodes. .. Jakubowska et al ( ) , 2024 , Poland , Renal Failure , Prospective cross-sectional study , 8 (7 with PTDM and 1 with existing DM) , Kidney transplant (2 -23 months post-transplant) Dexcom G6 , To evaluate glycemic profiles using the Article Title: Role of automated insulin delivery in managing insulin-treated outpatients with type 2 diabetes: A systematic review and meta-analysis Article Snippet: Daly et al [ ], 2023, two centers in United Kingdom , Cross-over, NCT04701424 , Age ≥ 18 years, subcutaneous insulin therapy, HbA1c ≤ 11% , AID , CamAPS HX Closed-loop (Dana insulin pump, Dexcom G6 real-time CGM system, and CamAPS HX Application v.0.3.71) , 26 , 59 ± 11 , 9.0 ± 1.4 , 17.5 ± 8.2 , TIR, TAR, TBR, HbA1c, mean sensor glucose, coefficient of glucose variation, TDDI, AEs , 16 weeks (two therapy: 8 weeks therapy of closed loop and standard insulin therapy). .. Control , MDI and Article Title: Prospective multicenter evaluation of glycemic and patient-reported outcomes following transition to a next-generation continuous glucose monitoring system in users of advanced hybrid closed-loop technology Article Snippet: .. The study recruited individuals with T1D from diabetes care centers who met the following inclusion criteria: (i) Diagnosis of T1D; (ii) Age ⩾18 years; (iii) Current use of the Tandem t:Slim X2 insulin pump with Control-IQ; (iv) Prior use of the Transplantation Assay:Article Title: Improving kidney transplant care through the application of continuous glucose monitoring - a narrative review Article Snippet: Jandovitz et al ( ) , 2023 , USA , Clinical Transplant , Prospective randomized controlled trial , 40 , Kidney transplant Medtronic , To examine whether the use of inpatient Continuous Glucose Monitors provides improved glycemic control over finger-stick glucose monitoring post-transplant. , Patients on CGM has significantly reduced incidence of hyperglycaemic episodes and median glucose levels in the first 5 days post-transplant without increasing the number of hypoglycaemic episodes. .. Jakubowska et al ( ) , 2024 , Poland , Renal Failure , Prospective cross-sectional study , 8 (7 with PTDM and 1 with existing DM) , Kidney transplant (2 -23 months post-transplant) Dexcom G6 , To evaluate glycemic profiles using the other:Article Title: Quantifying the global eco-footprint of wearable healthcare electronics. Article Snippet: Wearable healthcare electronics are rapidly emerging as a distinct electronics sector in the digital era, offering substantial economic opportunities and crucial medical benefits.. However, their interactions with environmental and social systems remain poorly understood, leaving critical sustainability challenges unaddressed.. Although current efforts have focused on material-level improvements, broader system-level dynamics remain unexplored. Article Title: Continuous Glucose Monitoring and Maternal and Neonatal Morbidity in Pregnant People With Type 1 Diabetes Article Snippet: This is a retrospective cohort study of a convenience sample of pregnant people with T1DM using the Article Title: Federated multimodal AI for precision-equitable diabetes care Article Snippet: It has been demonstrated that the Biomarker Discovery:Article Title: Prospective multicenter evaluation of glycemic and patient-reported outcomes following transition to a next-generation continuous glucose monitoring system in users of advanced hybrid closed-loop technology Article Snippet: .. The study recruited individuals with T1D from diabetes care centers who met the following inclusion criteria: (i) Diagnosis of T1D; (ii) Age ⩾18 years; (iii) Current use of the Tandem t:Slim X2 insulin pump with Control-IQ; (iv) Prior use of the |